Looking for a trusted supplier of Apalutamide 60 mg Tablets for prostate cancer treatment? Cordium Pharmaceuticals Pvt Ltd is a reliable pharmaceutical exporter from India delivering high-quality oncology medicines worldwide with fast, affordable, and secure shipping.
As demand for advanced prostate cancer therapies continues to rise globally, Apalutamide has become one of the most searched and prescribed androgen receptor inhibitor medicines for patients with metastatic and non-metastatic prostate cancer. Recent industry updates also highlight growing approvals and market expansion for Apalutamide 60 mg tablets in international markets.
What is Apalutamide 60 mg?
Apalutamide is an advanced anti-cancer medication used in the treatment of prostate cancer. It works by blocking androgen receptors that help prostate cancer cells grow and spread. Medical sources describe Apalutamide as an androgen receptor inhibitor commonly used for metastatic castration-sensitive and non-metastatic castration-resistant prostate cancer.
Product Details
Product Name: Apalutamide 60 mg Tablets
Medicine Category: Anti-Cancer / Oncology Medicine
Strength: 60 mg
Dosage Form: Oral Tablets
Treatment: Prostate Cancer
Packaging: Export-quality secure packaging
Manufacturer & Exporter: Cordium Pharmaceuticals Pvt Ltd
Origin Country: India
Uses of Apalutamide 60 mg Tablets
Apalutamide is prescribed for:
Metastatic Castration-Sensitive Prostate Cancer (mCSPC)
Non-Metastatic Castration-Resistant Prostate Cancer (nmCRPC)
Advanced prostate cancer management
Hormone-sensitive prostate cancer therapy
Clinical and pharmaceutical references state that Apalutamide helps slow cancer progression by blocking androgen activity in prostate cancer cells.
How Apalutamide Works
Prostate cancer cells depend on male hormones (androgens) for growth. Apalutamide blocks androgen receptor signaling, helping reduce tumor progression and improving disease control in eligible patients.
Benefits of Apalutamide 60 mg Tablets
Helps slow prostate cancer progression
Supports long-term cancer management
Advanced androgen receptor inhibitor therapy
Oral tablet for convenient administration
Used in modern oncology treatment protocols
Globally recognized prostate cancer medicine
Recommended Dosage
The dosage of Apalutamide 60 mg Tablets should always be taken strictly under medical supervision. Standard prescribing information notes oral daily dosing depending on patient condition and physician recommendations.
⚠️ Important: Do not self-medicate. Always consult an oncologist or healthcare professional before starting treatment.
Possible Side Effects
Some patients may experience:
Fatigue
Skin rash
Joint pain
Weight loss
High blood pressure
Diarrhea
Hot flashes
Medical references and patient experiences also mention fatigue, rash, and headache among reported effects.
Why Choose Cordium Pharmaceuticals Pvt Ltd?
Trusted Global Pharmaceutical Exporter from India
At Cordium Pharmaceuticals Pvt Ltd, we are committed to supplying genuine oncology medicines worldwide with professional export support.
Our Key Advantages
Genuine quality pharmaceutical products
Competitive and affordable pricing
Fast international delivery
Reliable export documentation support
Secure packaging for global shipments
Responsive customer assistance
Trusted pharmaceutical exporter from India
Bulk order and institutional supply support
Countries We Serve
We provide reliable export and delivery services to:
United States
Germany
United Kingdom
Netherlands
South Africa
United Arab Emirates
Brazil
We ensure safe and timely pharmaceutical exports with global logistics support.
Order & Enquiry
WhatsApp:
📱 +91-9405117673
Email
📧 info@cordiumpharma.com
Website
www, cordiumpharma.com
Cordium Pharmaceuticals Pvt Ltd Official Website
For bulk orders, wholesale inquiries, hospital supply, or international export requirements, contact our team today for the best pricing and fast delivery support.
Latest Global Demand for Apalutamide
The global demand for Apalutamide 60 mg tablets continues to grow due to increasing awareness and adoption of advanced prostate cancer therapies. Recent reports highlight regulatory approvals and expanding market availability for Apalutamide-based medicines internationally.
As demand for advanced prostate cancer therapies continues to rise globally, Apalutamide has become one of the most searched and prescribed androgen receptor inhibitor medicines for patients with metastatic and non-metastatic prostate cancer. Recent industry updates also highlight growing approvals and market expansion for Apalutamide 60 mg tablets in international markets.
What is Apalutamide 60 mg?
Apalutamide is an advanced anti-cancer medication used in the treatment of prostate cancer. It works by blocking androgen receptors that help prostate cancer cells grow and spread. Medical sources describe Apalutamide as an androgen receptor inhibitor commonly used for metastatic castration-sensitive and non-metastatic castration-resistant prostate cancer.
Product Details
Product Name: Apalutamide 60 mg Tablets
Medicine Category: Anti-Cancer / Oncology Medicine
Strength: 60 mg
Dosage Form: Oral Tablets
Treatment: Prostate Cancer
Packaging: Export-quality secure packaging
Manufacturer & Exporter: Cordium Pharmaceuticals Pvt Ltd
Origin Country: India
Uses of Apalutamide 60 mg Tablets
Apalutamide is prescribed for:
Metastatic Castration-Sensitive Prostate Cancer (mCSPC)
Non-Metastatic Castration-Resistant Prostate Cancer (nmCRPC)
Advanced prostate cancer management
Hormone-sensitive prostate cancer therapy
Clinical and pharmaceutical references state that Apalutamide helps slow cancer progression by blocking androgen activity in prostate cancer cells.
How Apalutamide Works
Prostate cancer cells depend on male hormones (androgens) for growth. Apalutamide blocks androgen receptor signaling, helping reduce tumor progression and improving disease control in eligible patients.
Benefits of Apalutamide 60 mg Tablets
Helps slow prostate cancer progression
Supports long-term cancer management
Advanced androgen receptor inhibitor therapy
Oral tablet for convenient administration
Used in modern oncology treatment protocols
Globally recognized prostate cancer medicine
Recommended Dosage
The dosage of Apalutamide 60 mg Tablets should always be taken strictly under medical supervision. Standard prescribing information notes oral daily dosing depending on patient condition and physician recommendations.
⚠️ Important: Do not self-medicate. Always consult an oncologist or healthcare professional before starting treatment.
Possible Side Effects
Some patients may experience:
Fatigue
Skin rash
Joint pain
Weight loss
High blood pressure
Diarrhea
Hot flashes
Medical references and patient experiences also mention fatigue, rash, and headache among reported effects.
Why Choose Cordium Pharmaceuticals Pvt Ltd?
Trusted Global Pharmaceutical Exporter from India
At Cordium Pharmaceuticals Pvt Ltd, we are committed to supplying genuine oncology medicines worldwide with professional export support.
Our Key Advantages
Genuine quality pharmaceutical products
Competitive and affordable pricing
Fast international delivery
Reliable export documentation support
Secure packaging for global shipments
Responsive customer assistance
Trusted pharmaceutical exporter from India
Bulk order and institutional supply support
Countries We Serve
We provide reliable export and delivery services to:
United States
Germany
United Kingdom
Netherlands
South Africa
United Arab Emirates
Brazil
We ensure safe and timely pharmaceutical exports with global logistics support.
Order & Enquiry
WhatsApp:
📱 +91-9405117673
📧 info@cordiumpharma.com
Website
www, cordiumpharma.com
Cordium Pharmaceuticals Pvt Ltd Official Website
For bulk orders, wholesale inquiries, hospital supply, or international export requirements, contact our team today for the best pricing and fast delivery support.
Latest Global Demand for Apalutamide
The global demand for Apalutamide 60 mg tablets continues to grow due to increasing awareness and adoption of advanced prostate cancer therapies. Recent reports highlight regulatory approvals and expanding market availability for Apalutamide-based medicines internationally.
Keywords
